Magnetic chemiluminescent immunoassay for human C-reactive protein on the centrifugal microfluidics platform

被引:39
作者
Czilwik, G. [1 ]
Vashist, S. K. [1 ,2 ]
Klein, V. [1 ]
Buderer, A. [1 ]
Roth, G. [3 ,4 ]
von Stetten, F. [1 ,2 ]
Zengerle, R. [1 ,2 ,3 ]
Mark, D. [1 ]
机构
[1] Hahn Schickard, D-79110 Freiburg, Germany
[2] Univ Freiburg, IMTEK, Dept Microsyst Engn, Lab MEMS Applicat, D-79110 Freiburg, Germany
[3] Univ Freiburg, BIOSS, Ctr Biol Signalling Studies, D-79110 Freiburg, Germany
[4] Univ Freiburg, Ctr Biol Syst Anal ZBSA, Lab Microarray Copying, D-79104 Freiburg, Germany
关键词
ACUTE-PHASE PROTEINS; SENSITIVE DETECTION; CRP DETECTION; ASSAY SYSTEM; WHOLE-BLOOD; INFLAMMATION; HEALTH; SERUM; LAB; IMMUNOSENSOR;
D O I
10.1039/c5ra12527h
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Human C-reactive protein (CRP) has been reported as an inflammatory biomarker with the highest reference for use in clinical practice. However, the existing analytical techniques are lacking automation and simplicity, as desired for a prospective immunoassay format for point-of-care (PoC) analysis. We have developed an automated magnetic chemiluminescent immunoassay (MCIA) on a mobile analyser for rapid PoC determination of CRP. The MCIA is fully automated after the initial loading of sample and immunoreagents at the inlet ports. The automated protocol involves the transportation of magnetic capture microparticles between adjacent reaction compartments using a set of stationary magnets, a microfluidic polymer disposable and a specific centrifugal protocol. The developed MCIA has a sample-to-answer time of 25 min and hands-on time of approximately 5 min. It detects the entire pathophysiological range of CRP, as desired for clinically-relevant high sensitivity CRP immunoassay format, i.e. 3-81 ng mL(-1) in diluted human serum with a limit of detection (LOD) and limit of quantification (LOQ) of 1.5 ng mL(-1) and 1.8 ng mL(-1), respectively.
引用
收藏
页码:61906 / 61912
页数:7
相关论文
共 51 条
[1]   Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood [J].
Ahn, JS ;
Choi, S ;
Jang, SH ;
Chang, HJ ;
Kim, JH ;
Nahm, KB ;
Oh, SW ;
Choi, EY .
CLINICA CHIMICA ACTA, 2003, 332 (1-2) :51-59
[2]   Two immunoassay formats for fully automated CRP detection in human serum [J].
Albrecht, Christiane ;
Kaeppel, Nina ;
Gauglitz, Guenter .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 391 (05) :1845-1852
[3]   Current analytical strategies for C-reactive protein quantification in blood [J].
Algarra, Manuel ;
Gomes, Diana ;
Esteves da Silva, Joaquim C. G. .
CLINICA CHIMICA ACTA, 2013, 415 :1-9
[4]   High-sensitivity C-reactive protein: Clinical importance [J].
Bassuk, SS ;
Rifai, N ;
Ridker, PM .
CURRENT PROBLEMS IN CARDIOLOGY, 2004, 29 (08) :439-493
[5]   C-reactive protein [J].
Black, S ;
Kushner, I ;
Samols, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) :48487-48490
[6]  
Borque L, 2000, CLIN CHEM, V46, P1839
[7]   Plasma extraction by centrifugo-pneumatically induced gating of flow [J].
Burger, Robert ;
Reis, Nuno ;
da Fonseca, Joao Garcia ;
Ducree, Jens .
JOURNAL OF MICROMECHANICS AND MICROENGINEERING, 2013, 23 (03)
[8]   C reactive protein and procalcitonin. Reference intervals for preterm and term newborns during the early neonatal period [J].
Chiesa, Claudio ;
Natale, Fabio ;
Pascone, Roberto ;
Osborn, John F. ;
Pacifico, Lucia ;
Bonci, Enea ;
De Curtis, Mario .
CLINICA CHIMICA ACTA, 2011, 412 (11-12) :1053-1059
[9]   Application of microchip assay system for the measurement of C-reactive protein in human saliva [J].
Christodoulides, N ;
Mohanty, S ;
Miller, CS ;
Langub, MC ;
Floriano, PN ;
Dharshan, P ;
Ali, MF ;
Bernard, B ;
Romanovicz, D ;
Anslyn, E ;
Fox, PC ;
McDevitt, JT .
LAB ON A CHIP, 2005, 5 (03) :261-269
[10]   Sensitive detection of cardiac biomarker using ZnS nanoparticles as novel signal transducers [J].
Cowles, Chad L. ;
Zhu, Xiaoshan .
BIOSENSORS & BIOELECTRONICS, 2011, 30 (01) :342-346